INDOCO REMEDIES
Back to Balance Sheet
|
INDOCO REMEDIES Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹163 Cr | ₹164 Cr | ₹89 Cr | ₹60 Cr | ₹56 Cr |
What is the latest Contingent Liabilities ratio of INDOCO REMEDIES ?
| Year | Contingent Liabilities |
|---|---|
| Mar2025 | ₹163 Cr |
| Mar2024 | ₹164 Cr |
| Mar2023 | ₹89 Cr |
| Mar2022 | ₹60 Cr |
| Mar2021 | ₹56 Cr |
How is Contingent Liabilities of INDOCO REMEDIES Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹163 Cr | -0.60 | |
| Mar2024 | ₹164 Cr | 83.75 | |
| Mar2023 | ₹89 Cr | 48.09 | |
| Mar2022 | ₹60 Cr | 7.79 | |
| Mar2021 | ₹56 Cr | - | |
Compare Contingent Liabilities of peers of INDOCO REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INDOCO REMEDIES | ₹2,381.1 Cr | -1% | -10.3% | -18.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹427,034.0 Cr | 0.9% | 5.3% | 1.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹169,211.0 Cr | -2.3% | -3.3% | 12.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹124,875.0 Cr | -3.3% | 2.8% | 19.7% | Stock Analytics | |
| CIPLA | ₹122,082.0 Cr | -1.6% | -9.2% | 4.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,873.0 Cr | NA | -3.5% | 4.6% | Stock Analytics | |
INDOCO REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INDOCO REMEDIES | -1% |
-10.3% |
-18.2% |
| SENSEX | 0.8% |
1% |
9.9% |
You may also like the below Video Courses